Form 4: Supernus Pharmaceuticals Executive Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, disposed of shares to cover tax withholding requirements related to vesting Restricted Stock Units.
Summary
- On March 5, 2025, Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, reported disposing of common stock to cover tax obligations.
- The transactions involved the withholding of 335, 575, and 575 shares at a price of $33.05 per share.
- Following these transactions, Bhatt's direct ownership of Supernus Pharmaceuticals common stock decreased from 13,854 to 12,704 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to routine stock disposals for tax purposes, with no indication of positive or negative implications for the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common when restricted stock units vest.
Stakeholder Impact
- The stock disposal has a minimal impact on shareholders as it is related to tax obligations and does not indicate a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock disposal transactions and filing date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.